ROCKEBY AWARDED BIRD FLU TESTS TENDER FROM MIDDLE EAST...

ROCKEBY AWARDED BIRD FLU TESTS TENDER FROM MIDDLE EAST

Australian-listed Singapore-based healthcare company group Rockeby biomed Ltd (ASX: RBY) is pleased to announce that it has received its first tender award for its Avian Influenza Virus kits from the Middle Eastern nation of Jordan.
Rockeby Chief Executive Dr Sze-Wee Tan said the company has been awarded the national tender for 1,500 bird flu tests in Jordan. In addition to this, the company this
week has also received separate orders for bird flu tests both from Pasteur Institute’s laboratory in Tunisia and from the state of Brunei Darussalam.
“ Payment for the Jordan tender has already been received, and the tests will be shipped
to Jordan later this month,” Dr Tan said. “This together with the Pasteur Institute and the Brunei order further demonstrate the growing acceptance of Rockeby’s Avian Influenza Virus test kit in diverse global markets
where the threat of Avian Flu still remains.
“We have tenders for several countries including Italy and Switzerland, which are still pending.”
Rockeby’s Avian Flu rapid tests have been sold in singapore, Malaysia, Thailand and other Middle Eastern markets. Rockeby has distributors for Eygpt, Libya, Palestine, UAE, Yemen. The rapid test is currently used by the Thailand and Indonesia government in the bird flu outbreak there.
The Rockeby Avian Influenza Virus Antigen Test is for the detection of influenza A virus, including the H5N1 subtype, as a veterinary diagnostic for on-site testing of bird throat and faeces.
It relies on immunological detection of viral protein and have the advantage of being selfcontained and yielding the result within 10 minutes of application of the sample to the testing device.